Annex 13 gmp ema






EUROPEAN COMMISSION Brussels 03 February 2010 EudraLex

3 févr. 2010 EU Guidelines to. Good Manufacturing Practice. Medicinal Products for Human and Veterinary Use. Annex 13. Investigational Medicinal Products.
annex


CHMP Minutes and Annex 13-16 December 2021

8 févr. 2022 EMA/CHMP/782804/2021. Human Medicines Division. Committee for medicinal products for human use (CHMP). Minutes for the meeting on 13-16 ...
minutes chmp meeting december en


EU GMP Requirements

Focal points of inspections at IMP manufacturing sites. ▫ Revision of Annex 13 – current status. ▫ GMP level of Active Ingredients for Use in IMPs 
eu gmp requirements investigational medicinal products bernd boedecker en


Annual report of the Good Manufacturing and Distribution Practice

12 sept. 2016 Send a question via our website www.ema.europa.eu/contact ... GMP Guide: Annex 13 (Manufacture of Investigational Medicinal Products) .
annual report good manufacturing distribution practice inspectors working group en





Annex 19 Reference and Retention Samples

14 déc. 2005 This Annex to the Guide to Good Manufacturing Practice for Medicinal ... for investigational medicinal products are given in Annex 13 to the.
b b cf a b ccfcd d en?filename= annex en


Reflection paper on the use of interactive response technologies

10 déc. 2013 Send us a question Go to www.ema.europa.eu/contact ... expiry date expiry update labelling
WC


Reflection paper on the use of interactive response technologies

10 déc. 2013 Send us a question Go to www.ema.europa.eu/contact ... expiry date expiry update labelling
web response systems clinical trials particular emphasis handling expiry dates en


Reflection Paper on Good Manufacturing Practice and Marketing

10 janv. 2022 Annex 12 Paragraph 33). Page 10. EMA/INS/3094/2022. Page 10/29.
reflection paper good manufacturing practice marketing authorisation holders en





guide to good manufacturing practice for medicinal products annexes

1 févr. 2022 Annex 13 (Manufacture of investigational medicinal products) ... Annex 18 [GMP Guide for active pharmaceutical ingredients]**.


Guideline on the Investigation of Bioequivalence

1 août 2010 E-mail: mail@ema.europa.eu http://www.ema.europa.eu ... in accordance with good manufacturing practice including Annex 13 to the EU.
guideline investigation bioequivalence rev en


0